Perioperative blood transfusion is one of the factors that affect the prognosis of gastric cancer.

PURPOSE To demonstrate the potential significance of perioperative blood transfusion on the prognosis of gastric cancer. METHODS Data from 234 patients who were subjected to radical gastrectomy in our hospital were obtained and retrospectively analyzed. Patients' age, gender, preoperative anemia, tumor size, location, invasion depth, lymph node metastasis, TNM stage, presence or absence of blood transfusion and blood transfusion volume were observed and analyzed. RESULTS The difference of tumor recurrence in patients whose blood transfusion volume was greater than 2U was significant (p<0.001). The tumor recurrence in patients whose blood transfusion was less than 2U was significantly shorter than in those whose transfusion volume was greater than 4U (p=0.03). The survival in the blood transfusion group was significantly lower in comparison with the nonblood transfusion group (p=0.002). The survival of transfusion group in TNM stage III and IV was significantly shorter than that in non-transfusion group (p=0.03). Statistical significance was found in survival between the transfusion group and non-transfusion group when the tumor size was less than 5 cm and greater than 5 cm (p=0.006, p=0.04, respectively). CONCLUSIONS Perioperative transfusion is one of the factors for predicting the prognosis of postoperative gastric cancer patients, and the larger the perioperative transfusion, the shorter the tumor recurrence, the worse the prognosis. Therefore, it is of great significance reducing the intraoperative blood loss and strict controlling blood transfusion indications.

[1]  Yunfeng Fu,et al.  Impact of perioperative blood transfusion on survival of patients undergoing laparoscopic gastrectomy for gastric cancer. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[2]  M. Kanda,et al.  Adverse Effects of Intraoperative Blood Loss on Long-Term Outcomes after Curative Gastrectomy of Patients with Stage II/III Gastric Cancer , 2016, Digestive Surgery.

[3]  Mitsuro KandaDaisuke Adverse prognostic impact of perioperative allogeneic transfusion on patients with stage II/III gastric cancer , 2016 .

[4]  A. Ejaz,et al.  Effect of Perioperative Transfusion on Recurrence and Survival after Gastric Cancer Resection: A 7-Institution Analysis of 765 Patients from the US Gastric Cancer Collaborative. , 2015, Journal of the American College of Surgeons.

[5]  A. Rudensky,et al.  A Distinct Function of Regulatory T Cells in Tissue Protection , 2015, Cell.

[6]  Hai-yang Zhou,et al.  Association of perioperative allogeneic blood transfusions and prognosis of patients with gastric cancer after curative gastrectomy. , 2014, American journal of surgery.

[7]  Jianrong Guo,et al.  Impact of allogenic and autologous transfusion on immune function in patients with tumors. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[8]  G. Dionigi,et al.  Peri-operative blood transfusion in gastric cancer surgery: prognostic or confounding factor? , 2013, International journal of surgery.

[9]  Seung-Moo Noh,et al.  Prognostic Significance of Preoperative Blood Transfusion in Stomach Cancer , 2010, Journal of gastric cancer.

[10]  E. Vamvakas,et al.  Transfusion-related immunomodulation (TRIM): an update. , 2007, Blood reviews.

[11]  S. Chattopadhyay,et al.  Regulatory T cells and tumor immunity , 2005, Cancer Immunology, Immunotherapy.

[12]  C. Velde,et al.  The effects of blood transfusion on the prognosis of patients with gastric cancer , 1989, World Journal of Surgery.

[13]  M. Tachibana,et al.  A Tailored Perioperative Blood Transfusion Might Avoid Undue Recurrences in Gastric Carcinoma Patients , 2000, Digestive Diseases and Sciences.

[14]  P. Parrilla,et al.  Does Perioperative Blood Transfusion Influence Long-Term Prognosis of Gastric Cancer? , 1997, Digestive Diseases and Sciences.

[15]  A. Kakkar,et al.  Enhanced angiogenesis following allogeneic blood transfusion. , 2004, Clinical and Laboratory Haematology.

[16]  D. Balzi,et al.  Long-term prognosis of gastric cancer in a European country: a population-based study in Florence (Italy). 10-year survival of cases diagnosed in 1985-1987. , 2001, European journal of cancer.

[17]  A. Merlo,et al.  In vitro immunosuppressive activity of soluble HLA class I and Fas ligand molecules:do they play a role in autologous blood transfusion? , 2001, Transfusion.

[18]  S. Haga,et al.  Influence of perioperative blood transfusion on the prognosis of patients with gastric cancer receiving anticancer chemotherapy , 2000, Gastric Cancer.

[19]  Y. Maehara,et al.  Lack of relationship between perioperative blood transfusion and survival time after curative resection for gastric cancer , 1990, Cancer.

[20]  N. Kaibara,et al.  Blood transfusion and the prognosis of patients with gastric cancer , 1989, Journal of surgical oncology.

[21]  K. Orita,et al.  Adverse affect of blood transfusions on survival of patients with gastric cancer , 1987, Transfusion.

[22]  P. Tartter,et al.  EFFECT OF BLOOD TRANSFUSIONS ON COLONIC MALIGNANCY RECURRENCE RATE , 1982, The Lancet.